Terms: = Colorectal cancer AND SLC34A2, ENSG00000157765, O95436, NPTIIb, NAPI-IIb, NAPI-3B, FLJ90534, 10568 AND Treatment
3 results:
1. Rectal neuroendocrine tumors in a colon cancer screening colonoscopy program. Sixteen-year single institution experience.
Dąbkowski K; Michalska K; Rusiniak-Rosińska N; Urasińska E; Bielicki D; Starzyńska T
Scand J Gastroenterol; 2023 Mar; 58(3):310-313. PubMed ID: 36121191
[TBL] [Abstract] [Full Text] [Related]
2. Solute carrier family 34 member 2 overexpression contributes to tumor growth and poor patient survival in colorectal cancer.
Liu L; Yang Y; Zhou X; Yan X; Wu Z
Biomed Pharmacother; 2018 Mar; 99():645-654. PubMed ID: 29653487
[TBL] [Abstract] [Full Text] [Related]
3. ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers.
Roskoski R
Pharmacol Res; 2017 Jul; 121():202-212. PubMed ID: 28465216
[TBL] [Abstract] [Full Text] [Related]
